| 000 | 01349 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513185903.0 | ||
| 264 | 0 | _c19990812 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0077-8923 | ||
| 024 | 7 |
_a10.1111/j.1749-6632.1999.tb11339.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZwart, R | |
| 245 | 0 | 0 |
_aPhysostigmine and atropine potentiate and inhibit neuronal alpha 4 beta 4 nicotinic receptors. _h[electronic resource] |
| 260 |
_bAnnals of the New York Academy of Sciences _cApr 1999 |
||
| 300 |
_a636-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcholine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAtropine _xpharmacology |
| 650 | 0 | 4 |
_aCholinergic Agonists _xpharmacology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHippocampus _xmetabolism |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aOocytes _xmetabolism |
| 650 | 0 | 4 | _aPatch-Clamp Techniques |
| 650 | 0 | 4 |
_aPhysostigmine _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Nicotinic _xdrug effects |
| 650 | 0 | 4 | _aXenopus |
| 700 | 1 | _aVan Kleef, R G | |
| 700 | 1 | _aVijverberg, H P | |
| 773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 868 _gp. 636-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1749-6632.1999.tb11339.x _zAvailable from publisher's website |
| 999 |
_c10372406 _d10372406 |
||